Found 0 matching trials
Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 PHASE2 Interferon lambda is one of the main arms of the innate antiviral immune re...
Show More Location
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Learn More & Join Trial
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin PHASE2 Substudy C: The purpose of this substudy is to determine whether Lambda com...
Show More Location
Alamo Medical Research
Learn More & Join Trial
A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection PHASE2 To evaluate safety and tolerability of lambda over a 48-week treatment peri...
Show More Location
Soroka Medical Center
Learn More & Join Trial
Safety Study of Pegylated Interferon Lambda Plus Single or 2 Direct Antiviral Agents With Ribavirin PHASE2 The purpose of this study is to determine if combination therapy with Pegyl...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
TOGETHER - Toronto: Trial to Evaluate the Effect of Peginterferon Lambda for the Treatment of COVID-19 PHASE3 Interferon (IFN) lambda is one of the fundamental responses of the innate i...
Show More Location
Toronto General Hospital
Learn More & Join Trial
Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV PHASE3 The Phase 3 LIMT-2 study will evaluate the safety and efficacy of Peginterf...
Show More Location
Asian Pacific Liver Center at Coalition of Inclusive Medicine
Learn More & Join Trial
Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV PHASE3 To evaluate Sustained Virologic Response at post treatment Week 12 (SVR12)f...
Show More Location
Inland Empire Liver Foundation
Learn More & Join Trial